Literature DB >> 15871242

Levels of hexabromocyclododecane in harbor porpoises and common dolphins from western European seas, with evidence for stereoisomer-specific biotransformation by cytochrome p450.

Bart N Zegers1, Anchelique Mets, Ronald Van Bommel, Chris Minkenberg, Timo Hamers, Jorke H Kamstra, Graham J Pierce, Jan P Boon.   

Abstract

Commercial hexabromocyclododecane (HBCD) is a high-production-volume flame-retardant applied in polystyrene foams. It contains three stereoisomers, of which gamma-HBCD always dominates. Here we report on the levels of HBCD in blubber of harbor porpoise and common dolphin from different European seas. The highest total (sigma)-HBCD levels were measured in harbor porpoises stranded on the Irish and Scottish coasts of the Irish Sea (median concentration 2.9 microg (g of lipid)(-1)) and the northwest coast of Scotland (median concentration 5.1 microg (g of lipid)(-1)). The median levels in other areas were, for the harbor porpoise south coast of Ireland, 1.2 microg (g of lipid)(-1), for the coasts of The Netherlands, Belgium, and France north of Calais (southern North Sea), 1.1 microg (g of lipid)(-1), for the east coast of Scotland (northern North Sea), 0.77 microg (g of lipid)(-1), and, for Galicia (Spain), 0.1 microg (g of lipid)(-1). The median levels for the common dolphin were, for west coast of Ireland, 0.9 microg (g of lipid)(-1), for the French coast of the English Channel between Normandy and Brest, 0.4 microg (g of lipid)(-1), and, for Galicia, 0.2 microg (g of lipid)(-1). A subset of 10 harbor porpoise and 9 common dolphin blubber samples representing all areas were analyzed by LC/MS to determine the diastereomeric composition of their HBCD residues. All samples showed exclusively the peak of alpha-HBCD. To test if biotransformation by the cytochrome P450 system could explain the observed compositional difference with technical HBCD mixtures, a number of in vitro assays with microsomal preparations of liver were carried out. We had to revert to material stored at -80 degrees C from laboratory rats and a fresh harbor seal found dead in the Dutch Wadden Sea, since such liver samples of cetaceans were not in our possession. The in vitro assays showed that beta- and gamma-HBCDs were indeed significantly metabolized when incubated in the presence of NADPH as electron donor, compared to a set of reference samples which were identical except for the addition of NADPH. In contrast, the peak of alpha-HBCD did not decrease significantly in the presence of NADPH. In separate microsomal assays with beta- and gamma-HBCDs, new peaks of brominated compounds (signal at m/z = 79 or 81) with masses of [M + 0] were formed only when NADPH was added. This confirms the process of cytochrome P450 mediated biotransformation. Although rat and harbor seal belong to different families of the mammalia than the cetaceans, we propose that biotransformation by the cytochrome P450 system is also the most likely process to explain the exclusive accumulation of alpha-HBCD in harbor porpoise and common dolphin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871242     DOI: 10.1021/es049209t

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  9 in total

1.  Kinetic study of γ-hexabromocyclododecane orally given to laying hens (Gallus domesticus). "Transfer of HBCD in laying hens".

Authors:  Agnès Fournier; Cyril Feidt; Philippe Marchand; Anaïs Vénisseau; Bruno Le Bizec; Nadine Sellier; Erwan Engel; Jérémy Ratel; Angélique Travel; Catherine Jondreville
Journal:  Environ Sci Pollut Res Int       Date:  2011-08-02       Impact factor: 4.223

2.  Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food.

Authors:  Dieter Schrenk; Margherita Bignami; Laurent Bodin; James Kevin Chipman; Jesús Del Mazo; Bettina Grasl-Kraupp; Christer Hogstrand; Laurentius Ron Hoogenboom; Jean-Charles Leblanc; Carlo Stefano Nebbia; Elsa Nielsen; Evangelia Ntzani; Annette Petersen; Salomon Sand; Tanja Schwerdtle; Heather Wallace; Diane Benford; Peter Fürst; Martin Rose; Sofia Ioannidou; Marina Nikolič; Luisa Ramos Bordajandi; Christiane Vleminckx
Journal:  EFSA J       Date:  2021-03-08

3.  The fate of β-hexabromocyclododecane in female C57BL/6 mice.

Authors:  J Michael Sanders; Gabriel A Knudsen; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2013-06-02       Impact factor: 4.849

4.  Novel and distinct metabolites identified following a single oral dose of α- or γ-hexabromocyclododecane in mice.

Authors:  Heldur Hakk; David T Szabo; Janice Huwe; Janet Diliberto; Linda S Birnbaum
Journal:  Environ Sci Technol       Date:  2012-12-03       Impact factor: 9.028

5.  Hexabromocyclododecane (HBCD) stereoisomers in U.S. food from Dallas, Texas.

Authors:  Arnold Schecter; David T Szabo; James Miller; Tyra L Gent; Noor Malik-Bass; Malte Petersen; Olaf Paepke; Justin A Colacino; Linda S Hynan; T Robert Harris; Sunitha Malla; Linda S Birnbaum
Journal:  Environ Health Perspect       Date:  2012-05-31       Impact factor: 9.031

Review 6.  Advances in Instrumental Analysis of Brominated Flame Retardants: Current Status and Future Perspectives.

Authors:  Mohamed Abou-Elwafa Abdallah
Journal:  Int Sch Res Notices       Date:  2014-10-28

7.  Exposure to hexabromocyclododecanes (HBCDs) via dust ingestion, but not diet, correlates with concentrations in human serum: preliminary results.

Authors:  Laurence Roosens; Mohamed Abou-Elwafa Abdallah; Stuart Harrad; Hugo Neels; Adrian Covaci
Journal:  Environ Health Perspect       Date:  2009-07-13       Impact factor: 9.031

8.  Brominated flame retardants in North-East Atlantic marine ecosystems.

Authors:  Bjørn Munro Jenssen; Eugen G Sørmo; Kine Baek; Jenny Bytingsvik; Hege Gaustad; Anders Ruus; Janneche Utne Skaare
Journal:  Environ Health Perspect       Date:  2007-12       Impact factor: 9.031

9.  Lethal and Sublethal Toxicity Comparison of BFRs to Three Marine Planktonic Copepods: Effects on Survival, Metabolism and Ingestion.

Authors:  Wenjing Gong; Liyan Zhu; Ya Hao
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.